Literature DB >> 4981498

Rifampicin in treatment of experimental tuberculosis in mice.

J Batten.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4981498     DOI: 10.1016/0041-3879(69)90054-3

Source DB:  PubMed          Journal:  Tubercle        ISSN: 0041-3879


× No keyword cloud information.
  7 in total

Review 1.  [Results of chemotherapy in tuberculosis].

Authors:  E Jancik
Journal:  Pneumonologie       Date:  1971

2.  Adverse reactions to daily and intermittent rifampicin regimens for pulmonary tuberculosis in Hong Kong.

Authors:  M Aquinas; W G Allan; P A Horsfall; P K Jenkins; W Hung-Yan; D Girling; R Tall; W Fox
Journal:  Br Med J       Date:  1972-03-25

3.  Potentially serious side effects of high-dose twice-weekly rifampicin.

Authors:  G Poole; P Stradling; S Worlledge
Journal:  Br Med J       Date:  1971-08-07

Review 4.  Rifampicin: a review.

Authors: 
Journal:  Drugs       Date:  1971       Impact factor: 9.546

5.  In vitro bactericidal and in vivo therapeutic activities of a new rifamycin derivative, KRM-1648, against Mycobacterium tuberculosis.

Authors:  T Yamamoto; R Amitani; K Suzuki; E Tanaka; T Murayama; F Kuze
Journal:  Antimicrob Agents Chemother       Date:  1996-02       Impact factor: 5.191

Review 6.  Rifampin.

Authors:  M Schonell; E Dorken; S Grzybowski
Journal:  Can Med Assoc J       Date:  1972-04-08       Impact factor: 8.262

7.  Treatment of experimental staphylococcal infection with rifampin.

Authors:  M C Lobo; G L Mandell
Journal:  Antimicrob Agents Chemother       Date:  1972-09       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.